Overactive bladder is estimated to affect more than 33 million adults in the United States.
Sacral neuromodulation is a proven treatment option for bladder and bowel control. This treatment is delivered via an implantable system that sends mild electrical pulses through a lead to the sacral nerves to modulate the neural activity that influences the behavior of the pelvic floor, lower urinary track, urinary and anal sphincters, and colon.
Unlike oral medications that target the muscular component of bladder control, sacral neuromodulation offers control of symptoms through direct modulation of the nerve activity. While the precise mechanism of action of sacral neuromodulation has not been fully established, efficacy has been proven in clinical studies.
A distinct advantage of sacral neuromodulation is that it is tested for potential success prior to moving on to long-term therapy. The evaluation gives patients and physicians an opportunity to find out in as few as three to seven days whether adequate symptom reduction has been achieved.